Cover Image
市場調查報告書

MediPoint:MRI(核磁共振成像)設備--歐洲市場分析與預測

MediPoint: Magnetic Resonance Imaging Systems - EU Analysis and Market Forecasts

出版商 GlobalData 商品編碼 322144
出版日期 內容資訊 英文 179 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:MRI(核磁共振成像)設備--歐洲市場分析與預測 MediPoint: Magnetic Resonance Imaging Systems - EU Analysis and Market Forecasts
出版日期: 2014年12月31日 內容資訊: 英文 179 Pages
簡介

全球MRI(核磁共振成像)市場正處於變革期,特別是資本設備市場已達飽和狀態,多數企業正在開發新產品。另一方面,MRI自出現以來,由於其高度安全性及非侵入式受到高度評價,引進規模正在持續擴大。影像技術的急速進步及安全技術的發展,都關係到潛在性治療對象領域的擴大。法國低磁場核磁共振攝影市場還沒成立,但中磁場、高磁場MRI市場今後預測將大幅成長。MRI設備市場本身將是法國最急速成長的市場部門之一,預測到2020年將達到1億8100萬美金的規模。另一方面,英國高磁場MRI設備市場則由於醫療費給付制度尚未完善,最尖端系統的引進過晚等因素,2013年階段僅3080萬美金,是歐洲最小的市場。

本報告提供歐洲各國的核磁共振成像(以下簡稱MRI)設備市場相關分析,提供您設備的技術性特性和市場結構,目前未滿足需求,主要的推動及阻礙市場要素,今後的市場機會,現在正在開發的主要產品,地區整體及主要國家的市場趨勢(過去3年的實際成果值今後7年的預測值),各類型產品的詳細趨勢,主要企業簡介等調查。

第1章 目錄

第2章 簡介

第3章 產業概要

  • 核磁共振攝影技術概要
  • 系統概要
    • 預磁化場核磁共振攝影系統
    • 擴散核磁共振攝影
    • 表觀擴散係數
  • 技術的應用領域
  • 核磁共振攝影檢查之臨床上的適應範圍
  • 治療趨勢
    • 產品的生命週期
  • 技術的優點·缺點
    • 概要
    • 核磁共振攝影技術的SWOT分析
    • 核磁共振造影系統方面的幽閉恐懼症問題
    • 磁振造影(核磁共振攝影) vs. 電腦斷層攝影(CT)
  • 打入市場
    • 產品的生命週期
    • 購買意願決策
    • 團購組織所扮演的角色
  • 法規流程
  • 目前核磁共振攝影的醫療費給付趨勢
  • 治療趨勢
    • 神經學
    • 四肢核磁共振攝影
    • PET/MRI
    • EU5個國家
    • 磁共振血管造影術
    • 磁共振光譜學
    • 業務時間
    • 法規上的課題/回收
  • 經濟影響
    • 直接的費用
    • 核磁共振攝影系統的價格

第4章 未滿足需求

  • 概要
  • 實驗對象資料的保管·管理
  • 多參數核磁共振攝影
  • 帶給實驗對象高舒適性,高靜肅性的系統
  • 改善支援高畫質影像硬體用軟體
  • 容許量的高速化
  • 改善實驗對象的舒適性

第5章 市場機會分析

  • 概要
  • 掃描的標準化
  • 各種醫院引進MRI件數的擴大
  • 心臟用核磁共振攝影的普及
  • 腦發達研究的高磁場核磁共振攝影
  • 電力供給不穩定狀態下仍維持效能的永久磁石
  • 腦瘤的影像化
  • 無冷凍劑的冷卻系統
  • 門診病人檢驗用的追加掃描儀
  • 乳癌·前列腺癌症用核磁共振攝影
  • 癌症全身核磁共振攝影
  • 雲端運算的發達
  • 為了加快腦外傷的診斷速度的新技術

第6章 推動市場要素及障礙

  • 概要
  • 推動因素:改善更高磁場的影像取得能力
  • 推動因素:老化設備的低畫品質影像
  • 推動因素:核磁共振造影系統平均年齡老舊
  • 推動因素:老化設備難以取得同質訊號
  • 障礙:機器操作訓練用資源不足
  • 障礙:經濟壓力造成新設備引進規模縮小
  • 障礙:系統的誤用
  • 障礙:核磁共振攝影系統的任意驅使
  • 障礙:ISO(獨立型服務組織)--廠商的服務·新產品銷售代替的價錢比較便宜的替代方式
  • 障礙:超導性核磁共振攝影磁鐵廠商
  • 障礙:核磁共振攝影治療的醫療費給付額不一

第7章 競爭評估

  • 主要產品的完全簡介
    • Oasis (日立Medical)
    • Echelon Oval (日立Medical)
    • Discovery MR750w (GE Healthcare)
    • Optima MR360 Advance (GE Healthcare)
    • Optima MR450w (GE Healthcare)
    • Signa HDxt (GE Healthcare)
    • Vantage Titen (Philips Healthcare)
    • Ingenia (Philips Healthcare)
    • Achieva TX (Philips Healthcare)
    • Magnetom Aera (Siemens Healthcare)
    • Magnetom C! (Siemens Healthcare)
    • Magnetom Spectra (Siemens Healthcare)
    • NSM-S15 (Neusoft Medical Systems)
  • 基於磁力強度的分類
    • 低磁場核磁共振造影系統
    • 中磁場核磁共振造影系統
    • 高磁場核磁共振造影系統

第8章 開發平台評估

  • 11.7T MRI Sytem (Neurospin)
  • Aurora PET/MRI System (Aurora Imaging Technology)
  • Neona (Time Medical)
  • GE 7.0T MRI Scanner (GE Healthcare)
  • Signa PET/MRI (GE Healthcare)

第9章 現在及未來的主要企業

  • 概要
  • Aurora Imaging
  • China Resources Wandong Medical Equipment
  • Esaote S.p.A.
  • Fonar Corporation
  • GE Healthcare
  • 日立Medical
  • Hologic
  • Mindray
  • Neusoft Medical
  • Ningbo Xingaoyi Medical
  • Philips Healthcare
  • Siemens Healthcare
  • Time Medical
  • 東芝MedicalSystems

第10章 策略性的競爭評估

  • 各企業的市場佔有率

第11章 市場展望:各市場區隔

  • 各國市場明細

第12章 市場展望:各地區

  • EU5個國家
    • 歐盟5國的市場佔有率:各國
    • 市場規模:各市場區隔EU5個國家
  • 法國
    • 市場金額(以金額為準):各市場區隔
    • 核磁共振造影系統的用戶數(裝機量)
  • 德國
  • 義大利
  • 西班牙
  • 英國

第13章 附錄

圖表一覽

目錄
Product Code: GDME1124CFR

The global magnetic resonance imaging (MRI) market is a shifting, capital equipment market that is saturated with numerous players developing innovative technologies. Given their impressive safety and efficacy as well as non-invasive nature, MRI systems have seen continued adoption since they were first introduced to the healthcare market. Rapid advances in the field imaging along with the development of MRI safe technologies have greatly expanded the potential of therapeutic applications.

In France there is no market for low-field MRI system sales, although the market for mid- and high-field systems is expected to undergo significant growth in the coming years. MRI is one of the fastest growing device market segments in the country, and will be valued at over $181m by 2020. Valued at just $30.8m in 2013, the high-field MRI market in the UK is one of the smallest in Europe, due to poor reimbursement and slow adoption of advanced systems.

Scope

  • An overview of Magnetic Resonance Imaging Systems, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized the EU Magnetic Resonance Imaging Systems market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
  • Investigation of current and future market competition for Magnetic Resonance Imaging Systems.
  • Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
  • Competitor assessment including device approval analysis and device sales forecasts.
  • Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
  • Analysis of unmet needs within the market and opportunities for future players.
  • Technology trends evaluation to assess strength of pipeline.
  • An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
  • Company profiles including business description, financial overview and SWOT analysis.
  • Coverage of key market players.
  • Strategic assessment of the Magnetic Resonance Imaging Systems sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

  • Understand the trends shaping and driving the EU Magnetic Resonance Imaging Systems market.
  • Realize device preferences of physicians who have performed the tests already.
  • Access market sizing, forecasts and quantified growth opportunities in the EU Magnetic Resonance Imaging Systems market through 2018.
  • Quantify candidate patient populations to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Perform benchmarking analysis of growth opportunities against currently marketed products.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
  • What's the next big thing in the EU Magnetic Resonance Imaging Systems market landscape? Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Overview of MRI Technology
  • 3.2. System Overview
    • 3.2.1. Pre-Polarizing MRI Systems
    • 3.2.2. Diffusion MRI
    • 3.2.3. Apparent Diffusion Coefficient
  • 3.3. Applications of Technology
  • 3.4. Clinical Indications for MRI scans
  • 3.5. Procedure Trends
    • 3.5.1. Product Lifecycle
  • 3.6. Advantages and Disadvantages of Technology
    • 3.6.1. Overview
    • 3.6.2. MRI Technology SWOT Analysis
    • 3.6.3. Claustrophobia Issues with MRI Systems
    • 3.6.4. Magnetic Resonance Imaging vs. Computed Tomography
  • 3.7. Market Access
    • 3.7.1. Product Life Cycle
    • 3.7.2. Purchasing Decisions
    • 3.7.3. Role of Group Purchasing Organizations
  • 3.8. Regulatory Process
    • 3.8.1. EU
  • 3.9. Current MRI Reimbursement Trends
    • 3.9.1. EU
    • 3.9.2. France
    • 3.9.3. Germany
    • 3.9.4. Italy
    • 3.9.5. Spain
    • 3.9.6. UK
  • 3.10. Procedure Trends
    • 3.10.1. Neurology
    • 3.10.2. Extremity MRI
    • 3.10.3. PET/MRI
    • 3.10.4. 5EU
    • 3.10.5. Magnetic Resonance Angiography
    • 3.10.6. Magnetic Resonance Spectroscopy
    • 3.10.7. Hours of Operation
    • 3.10.8. Regulatory Issues/Recalls
  • 3.11. Economic Impact
    • 3.11.1. Direct Costs
    • 3.11.2. Pricing of MRI Systems

4. Unmet Needs

  • 4.1. Overview
  • 4.2. Storing and Managing Patient Data
  • 4.3. Multiparametric MRI
  • 4.4. Quieter Systems for Improved Patient Comfort
  • 4.5. Improved Software to Support Advanced Image Acquisition Hardware
  • 4.6. Faster Throughput
  • 4.7. Improvements in Patient Comfort

5. Market Opportunity Analysis

  • 5.1. Overview
  • 5.2. Standardization of Scans
  • 5.3. Increased Adoption of MRI Throughout the Hospital
  • 5.4. Cardiac MRI on the Rise
  • 5.5. High-Field MRI in Developing Brains
  • 5.6. Permanent Magnets Still Desirable Where Power Unreliable
  • 5.7. Imaging Brain Tumors
  • 5.8. Cryogen-Free Cooling Systems
  • 5.9. Additional Scanners for Outpatient Exams
  • 5.10. Breast and Prostate Cancer MRI
  • 5.11. Whole-Body MRI for Cancer
  • 5.12. Cloud Computing on the Rise
  • 5.13. New MRI Technique to Speed Up Diagnosis for Traumatic Brain Injury

6. Market Drivers and Barriers

  • 6.1. Overview
  • 6.2. Driver: Improved Imaging Capabilities of Higher Field Strength
  • 6.3. Driver: Low-Quality Images from Older Machines
  • 6.4. Driver: High Average Age of MRI Systems
  • 6.5. Driver: Difficulty of Achieving Homogenous Signals with Older Systems
  • 6.6. Barrier: Fewer Resources for Training on Machines
  • 6.7. Barrier: Economic Pressure Reduces New Systems Volume
  • 6.8. Barrier: Misuse of Systems
  • 6.9. Barrier: Overuse of MRI Systems
  • 6.10. Barrier: ISOs a Cheaper Alternative to Service or New Sales from OEM
  • 6.11. Barrier: Supeconducting MRI Magnet Producers
  • 6.12. Barrier: Uneven Reimbursement for MRI Procedures

7. Competitive Assessment

  • 7.1. Full Profiles for Key Products
    • 7.1.1. Oasis (Hitachi)
    • 7.1.2. Echelon Oval (Hitachi)
    • 7.1.3. Discovery MR750w (GE Healthcare)
    • 7.1.4. Optima MR360 Advance (GE Healthcare)
    • 7.1.5. Optima MR450w (GE Healthcare)
    • 7.1.6. Signa HDxt (GE Healthcare)
    • 7.1.7. Vantage Titen (Philips Healthcare)
    • 7.1.8. Ingenia (Philips Healthcare)
    • 7.1.9. Achieva TX (Philips Healthcare)
    • 7.1.10. Magnetom Aera (Siemens Healthcare)
    • 7.1.11. Magnetom C! (Siemens Healthcare)
    • 7.1.12. Magnetom Spectra (Siemens Healthcare)
    • 7.1.13. NSM-S15 (Neusoft Medical Systems)
  • 7.2. Classification Based on Field Strength
    • 7.2.1. Low-Field MRI Systems
    • 7.2.2. Mid-Field MRI Systems
    • 7.2.3. High-Field MRI Systems

8. Pipeline Assessment

  • 8.1. 11.7T MRI System (Neurospin)
    • 8.1.1. Overview
    • 8.1.2. SWOT
  • 8.2. Aurora PET/MRI System (Aurora Imaging Technology)
    • 8.2.1. Overview
    • 8.2.2. SWOT
  • 8.3. Neona (Time Medical)
    • 8.3.1. Overview
    • 8.3.2. SWOT
  • 8.4. GE 7.0T MRI Scanner (GE Healthcare)
    • 8.4.1. Overview
    • 8.4.2. SWOT
  • 8.5. Signa PET/MRI (GE Healthcare)
    • 8.5.1. Overview
    • 8.5.2. SWOT

9. Current and Future Players

  • 9.1. Overview
  • 9.2. Aurora Imaging
    • 9.2.1. Overview
    • 9.2.2. Portfolio Assessment
    • 9.2.3. SWOT Analysis
  • 9.3. China Resources Wandong Medical Equipment
    • 9.3.1. Overview
    • 9.3.2. Portfolio Assessment
    • 9.3.3. SWOT Analysis
  • 9.4. Esaote S.p.A.
    • 9.4.1. Overview
    • 9.4.2. Portfolio Assessment
    • 9.4.3. SWOT Analysis
  • 9.5. Fonar Corporation
    • 9.5.1. Overview
    • 9.5.2. Portfolio Assessment
    • 9.5.3. SWOT Analysis
  • 9.6. GE Healthcare
    • 9.6.1. Overview
    • 9.6.2. Portfolio Assessment
    • 9.6.3. SWOT Analysis
  • 9.7. Hitachi Medical Corporation
    • 9.7.1. Overview
    • 9.7.2. Portfolio Assessment
    • 9.7.3. SWOT Analysis
  • 9.8. Hologic
    • 9.8.1. Overview
    • 9.8.2. Portfolio Assessment
    • 9.8.3. SWOT Analysis
  • 9.9. Mindray
    • 9.9.1. Overview
    • 9.9.2. Portfolio Assessment
    • 9.9.3. SWOT Analysis
  • 9.10. Neusoft Medical
    • 9.10.1. Overview
    • 9.10.2. Portfolio Assessment
    • 9.10.3. SWOT Analysis
  • 9.11. Ningbo Xingaoyi Medical
    • 9.11.1. Overview
    • 9.11.2. Portfolio Assessment
    • 9.11.3. SWOT Analysis
  • 9.12. Philips Healthcare
    • 9.12.1. Overview
    • 9.12.2. Portfolio Assessment
    • 9.12.3. SWOT Analysis
  • 9.13. Siemens Healthcare
    • 9.13.1. Overview
    • 9.13.2. Portfolio Assessment
    • 9.13.3. SWOT Analysis
  • 9.14. Sina Healthcare
    • 9.14.1. Overview
    • 9.14.2. Portfolio Assessment
    • 9.14.3. SWOT Analysis
  • 9.15. Time Medical
    • 9.15.1. Overview
    • 9.15.2. Portfolio Assessment
    • 9.15.3. SWOT Analysis
  • 9.16. Toshiba Medical Systems Corporation
    • 9.16.1. Overview
    • 9.16.2. Portfolio Assessment
    • 9.16.3. SWOT Analysis

10. Stategic Competitive Assessment

  • 10.1. Company Market Share
    • 10.1.1. 5EU
    • 10.1.2. France
    • 10.1.3. Germany
    • 10.1.4. Italy
    • 10.1.5. Spain
    • 10.1.6. UK

11. Market Outlooks by Market Segment

  • 11.1. Market Segment by Country
    • 11.1.1. France
    • 11.1.2. Germany
    • 11.1.3. Italy
    • 11.1.4. Spain
    • 11.1.5. UK

12. Market Outlooks by Geography

  • 12.1. 5EU
    • 12.1.1. 5EU Market Share by Country
    • 12.1.2. 5EU Market Value by Market Segment
  • 12.2. France
    • 12.2.1. Market Value by Market Segment
    • 12.2.2. Installed Base of MRI Systems
  • 12.3. Germany
    • 12.3.1. Market Value by Market Segment
    • 12.3.2. Installed Base of MRI Systems
  • 12.4. Italy
    • 12.4.1. Market Value by Market Segment
    • 12.4.2. Installed Base of MRI Systems
  • 12.5. Spain
    • 12.5.1. Market Value by Market Segment
    • 12.5.2. Installed Base of MRI Systems
  • 12.6. United Kingdom
    • 12.6.1. Market Value by Market Segment
    • 12.6.2. Installed Base of MRI Systems

13. Appendix

  • 13.1. Bibliography
  • 13.2. Abbreviations
  • 13.3. Report Methodology
    • 13.3.1. Overview
    • 13.3.2. Coverage
    • 13.3.3. Secondary Research
  • 13.4. Forecasting Methodology
  • 13.5. Primary Research - Key Opinion Leaders
  • 13.6. Primary Research - Physician and Industry Overviews
    • 13.6.1. Expert Panel Validation
  • 13.7. Physicians & Experts Included in this Study
  • 13.8. About the Authors
    • 13.8.1. Analysts
    • 13.8.2. Global Head of Healthcare
  • 13.9. About MediPoint
  • 13.10. About GlobalData
  • 13.11. Disclaimer

List of Tables

  • Table 1: MRI Procedure Targets
  • Table 2: Indications for an Immediate Emergency MRI
  • Table 3: Advantages and Disadvantages of MRI
  • Table 4: Magnetic Resonance Imaging Technology SWOT Analysis
  • Table 5: Selected Group Purchasing Organizations in the US and EU
  • Table 6: France Average Selling Price by Market Segment (2011-2020), $m
  • Table 7: Germany Average Selling Price by Market Segment (2011-2020), $m
  • Table 8: Italy Average Selling Price by Market Segment (2011-2020), $m
  • Table 9: Spain Average Selling Price by Market Segment (2011-2020), $m
  • Table 10: United Kingdom Average Selling Price by Market Segment (2011-2020), $m
  • Table 11: MRI Applications and Future Market Potential
  • Table 12: SWOT Analysis - Oasis
  • Table 13: SWOT Analysis - Echelon Oval
  • Table 14: SWOT Analysis - Discovery MR750w
  • Table 15: SWOT Analysis - Optima MR360 Advance
  • Table 16: SWOT Analysis - Optima MR450w
  • Table 17: SWOT Analysis - Signa HDxt
  • Table 18: SWOT Analysis - Vantage Titen
  • Table 19: SWOT Analysis - Ingenia
  • Table 20: SWOT Analysis - Achieva TX
  • Table 21: SWOT Analysis - Magnetom Aera
  • Table 22: SWOT Analysis - Magnetom C!
  • Table 23: SWOT Analysis - Magnetom Spectra
  • Table 24: SWOT Analysis - NSM-S15
  • Table 25: SWOT Analysis - Low-Field MRI Systems
  • Table 26: Low-Field MRI Systems
  • Table 27: SWOT Analysis - Mid-Field MRI Systems
  • Table 28: Mid-Field MRI Systems
  • Table 29: SWOT Analysis - High-Field MRI Systems
  • Table 30: High-Field MRI Systems
  • Table 31: SWOT Analysis - 11.7T MRI (Neurospin)
  • Table 32: SWOT Analysis - Aurora PET/MRI System (Aurora Imaging Technology)
  • Table 33: SWOT Analysis - Neona (Time Medical)
  • Table 34: SWOT Analysis - 7.0T MRI Scanner (GE Healthcare)
  • Table 35: SWOT Analysis - Signa PET/MR (GE Healthcare)
  • Table 36: Company Profile - Aurora Imaging
  • Table 37: Aurora Imaging, MRI System Device Portfolio
  • Table 38: SWOT Analysis - Aurora Imaging
  • Table 39: Company Profile - China Resources Wandong Medical Equipment
  • Table 40: China Resources Wandong Medical Equipment, MRI System Device Portfolio
  • Table 41: SWOT Analysis - China Resources Wandong Medical Equipment
  • Table 42: Company Profile - Esaote S.p.A.
  • Table 43: Esaote S.p.A., MRI System Device Portfolio
  • Table 44: SWOT Analysis - Esaote S.p.A.
  • Table 45: Company Profile - Fonar Corporation
  • Table 46: Fonar Corporation, MRI System Device Portfolio
  • Table 47: SWOT Analysis - Fonar Corporation
  • Table 48: Company Profile - GE Healthcare
  • Table 49: GE Healthcare, MRI System Device Portfolio
  • Table 50: SWOT Analysis - GE Healthcare
  • Table 51: Company Profile - Hitachi Medical Corporation
  • Table 52: Hitachi Medical Corporation, MRI System Device Portfolio
  • Table 53: SWOT Analysis - Hitachi Medical
  • Table 54: Company Profile - Hologic
  • Table 55: SWOT Analysis - Hologic
  • Table 56: Company Profile - Mindray
  • Table 57: Mindray, MRI System Device Portfolio
  • Table 58: SWOT Analysis - Mindray
  • Table 59: Company Profile - Neusoft Medical
  • Table 60: Neusoft Medical, MRI System Device Portfolio
  • Table 61: SWOT Analysis - Neusoft Medical
  • Table 62: Company Profile - Ningbo Xingaoyi Medical
  • Table 63: Ningbo Xingaoyi Magnetism, MRI System Device Portfolio
  • Table 64: SWOT Analysis - Ningbo Xingaoyi Magnetism
  • Table 65: Company Profile - Philips Healthcare
  • Table 66: Philips Healthcare, MRI System Device Portfolio
  • Table 67: SWOT Analysis - Philips Healthcare
  • Table 68: Company Profile - Siemens Healthcare
  • Table 69: Siemens Healthcare, MRI System Device Portfolio
  • Table 70: SWOT Analysis - Siemens Healthcare
  • Table 71: Company Profile - Sina Healthcare
  • Table 72: Sina Healthcare, MRI System Device Portfolio
  • Table 73: SWOT Analysis - Sina Healthcare
  • Table 74: Company Profile - Time Medical
  • Table 75: Time Medical, MRI System Device Portfolio
  • Table 76: SWOT Analysis - Time Medical
  • Table 77: Company Profile - Toshiba
  • Table 78: Toshiba, MRI System Device Portfolio
  • Table 79: SWOT Analysis - Toshiba
  • Table 80: 5EU Market Sales for MRI Systems (2012)
  • Table 81: France Market Sales for MRI Systems (2012)
  • Table 82: Germany Market Sales for MRI Systems (2012)
  • Table 83: Italy Market Sales for MRI Systems (2012)
  • Table 84: Spain Market Sales for MRI Systems (2012)
  • Table 85: United Kingdom Market Sales for MRI Systems (2012)
  • Table 86: France Market Segment, 2012 & 2020
  • Table 87: Germany Market Segment, 2012 & 2020
  • Table 88: Italy Market Segment, 2012 & 2020
  • Table 89: Spain Market Segment, 2012 & 2020
  • Table 90: United Kingdom Market Segment, 2012 & 2020
  • Table 91: 5EU Market by Country, 2012 & 2020
  • Table 92: 5EU Market Value by Market Segment for MRI Systems (2011-2020), $m
  • Table 93: France Market Value Forecast by Market Segment (2011-2020), $m
  • Table 94: France Installed Base of MRI Systems (2011-2020)
  • Table 95: Germany Market Value Forecast by Market Segment (2011-2020), $m
  • Table 96: Germany Installed Base of MRI Systems (2011-2020)
  • Table 97: Italy Market Value Forecast by Market Segment (2011-2020), $m
  • Table 98: Italy Installed Base of MRI Systems (2011-2020)
  • Table 99: Spain Market Value Forecast by Market Segment (2011-2020), $m
  • Table 100: Spain Installed Base of MRI Systems (2011-2020)
  • Table 101: United Kingdom Market Value Forecast by Market Segment (2011-2020), $m
  • Table 102: United Kingdom Installed Base of MRI Systems (2011-2020)
  • Table 103: Primary Research Interviews Completed by Country
  • Table 104: Primary Research Interviews Completed by Designation

List of Figures

  • Figure 1: France Average Selling Price by Market Segment
  • Figure 2: Germany Average Selling Price by Market Segment
  • Figure 3: Italy Average Selling Price by Market Segment
  • Figure 4: Spain Average Selling Price by Market Segment
  • Figure 5: United Kingdom Average Selling Price by Market Segment
  • Figure 6: Average Age for Magnetic Resonance Imaging Machines in 5EU in 2013
  • Figure 7: 5EU Market Share for MRI Systems (2012)
  • Figure 8: France Market Share for MRI Systems (2012)
  • Figure 9: Germany Market Share for MRI Systems (2012)
  • Figure 10: Italy Market Share for MRI Systems (2012)
  • Figure 11: Spain Market Share for MRI Systems (2012)
  • Figure 12: United Kingdom Market Share for MRI Systems (2012)
  • Figure 13: France Market Segment, 2012 & 2020
  • Figure 14: Germany Market Segment, 2012 & 2020
  • Figure 15: Italy Market Segment, 2012 & 2020
  • Figure 16: Spain Market Segment, 2012 & 2020
  • Figure 17: United Kingdom Market Segment, 2012 & 2020
  • Figure 18: 5EU Market by Country, 2012 & 2020
  • Figure 19: 5EU Market Value by Market Segment for MRI Systems (2011-2020), $m
  • Figure 20: France Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 21: France Installed Base of MRI Systems (2011-2020)
  • Figure 22: Germany Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 23: Germany Installed Base of MRI Systems (2011-2020)
  • Figure 24: Italy Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 25: Italy Installed Base of MRI Systems (2011-2020)
  • Figure 26: Spain Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 27: Spain Installed Base of MRI Systems (2011-2020)
  • Figure 28: United Kingdom Market Value Forecast by Market Segment (2011-2020), $m
  • Figure 29: United Kingdom Installed Base of MRI Systems (2011-2020)
  • Figure 30: Primary Research Interviews Completed by Country
  • Figure 31: Primary Research Interviews Completed by Designation
Back to Top